As the pan-European STOXX Europe 600 Index reaches new intraday highs, optimism about the eurozone economy is helping to counteract recent market volatility. In this environment, identifying undervalued stocks can be particularly appealing to investors seeking opportunities that may offer potential value as the broader market sentiment remains buoyant.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| Streamwide (ENXTPA:ALSTW) |
€73.20 |
€144.32 |
49.3% |
| Outokumpu Oyj (HLSE:OUT1V) |
€5.18 |
€10.19 |
49.1% |
| Nokian Panimo Oyj (HLSE:BEER) |
€2.47 |
€4.88 |
49.4% |
| Grieg Seafood (OB:GSF) |
NOK72.90 |
NOK143.53 |
49.2% |
| Exel Composites Oyj (HLSE:EXL1V) |
€0.536 |
€1.06 |
49.4% |
| Doxee (BIT:DOX) |
€4.33 |
€8.60 |
49.6% |
| Cambi (OB:CAMBI) |
NOK17.60 |
NOK34.79 |
49.4% |
| B&S Group (ENXTAM:BSGR) |
€5.85 |
€11.66 |
49.8% |
| Bike24 Holding (XTRA:BIKE) |
€3.04 |
€6.03 |
49.6% |
| Asker Healthcare Group (OM:ASKER) |
SEK70.65 |
SEK139.12 |
49.2% |
Let's dive into some prime choices out of the screener.
Laboratorios Farmaceuticos Rovi
Overview:Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company that manufactures, sells, and markets its products in Spain, the European Union, OECD countries, and internationally with a market cap of €3.85 billion.
Operations:Laboratorios Farmaceuticos Rovi generates its revenue through the manufacture, sale, and marketing of pharmaceutical products across Spain, the European Union, OECD countries, and other international markets.
Estimated Discount To Fair Value:34.2%
Laboratorios Farmaceuticos Rovi is trading at €75.2, significantly below its estimated future cash flow value of €114.25, presenting a potential undervaluation opportunity based on cash flows. The company's earnings are projected to grow 19.1% annually, outpacing the Spanish market's growth rate of 7.1%. Despite revenue growth being moderate at 10.6% per year, it still surpasses the Spanish market average of 5.6%, reinforcing its investment appeal in terms of cash flow valuation.
Sdiptech
Overview:Sdiptech AB (publ) offers technical services for infrastructures across various countries including Sweden, the UK, Germany, and others, with a market cap of SEK7.18 billion.
Operations:The company's revenue segments total SEK5.21 billion, derived from providing technical infrastructure services across multiple countries including Sweden, the UK, Germany, and others.
Estimated Discount To Fair Value:46%
Sdiptech AB is trading at SEK189, below its estimated future cash flow value of SEK349.91, highlighting a potential undervaluation. The company reported strong quarterly earnings with net income rising to SEK225 million from SEK107 million the previous year. Despite high debt levels and moderate revenue growth forecasts of 5.4% annually, Sdiptech's strategic focus on M&A could enhance cash flow generation, supported by their robust internal capabilities and recent executive appointments in energy and electrification sectors.
Partners Group Holding
Overview:Partners Group Holding AG is a private equity firm that focuses on direct, secondary, and primary investments in private equity, real estate, infrastructure, and debt with a market cap of CHF25.58 billion.
Operations:The company's revenue segments include CHF1.43 billion from Private Equity, CHF471.40 million from Infrastructure, CHF215.80 million from Real Estate, and CHF207.40 million from Private Credit.
Estimated Discount To Fair Value:27.7%
Partners Group Holding is trading at CHF986, significantly below its estimated future cash flow value of CHF1363.69, suggesting potential undervaluation. Despite high debt levels and a dividend yield of 4.26% not well covered by earnings or free cash flows, the company's earnings are forecast to grow at 10.16% annually, outpacing the Swiss market slightly. Recent strategic initiatives include launching multi-alternative SMA solutions with BlackRock and acquiring The Hoxton Poblenou hotel in Barcelona to enhance asset diversification and operational efficiency.
Key Takeaways
-
Unlock our comprehensive list of 208 Undervalued European Stocks Based On Cash Flows by clicking here.
-
Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
-
Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Searching for a Fresh Perspective?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BME:ROVI OM:SDIP B and SWX:PGHN.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
